XCUR - EXICURE, INC.
4.15
0.160 3.855%
Share volume: 6,978
Last Updated: 03-06-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.14%
PREVIOUS CLOSE
CHG
CHG%
$3.99
0.16
0.04%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 06-17-2024 | 08-13-2024 | 11-14-2024 | 03-18-2025 | 06-27-2025 | 08-08-2025 | 11-07-2025 | |
| Assets | ||||||||
| Total Assets | 10.711 M | 10.688 M | 10.631 M | 15.056 M | 20.680 M | 18.738 M | 15.267 M | |
| Current Assets | 1.463 M | 2.079 M | 2.600 M | 13.673 M | 11.305 M | 8.646 M | 5.439 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 366.000 K | 528.000 K | 343.000 K | 0.000 | 10.420 M | 7.858 M | 4.438 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 47.000 K | 40.000 K | 33.000 K | 26.000 K | 565.000 K | 712.000 K | 527.000 K | |
| Other Assets | 9.201 M | 8.569 M | 7.998 M | 1.357 M | 8.810 M | 9.380 M | 9.301 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | ||||||||
| Total Liabilities and shareholders’ equity | 10.711 M | 10.688 M | 10.631 M | 15.056 M | 20.680 M | 18.738 M | 15.267 M | |
| Total liabilities | 8.504 M | 9.075 M | 9.086 M | 8.284 M | 9.298 M | 9.875 M | 8.340 M | |
| Total current liabilities | 2.661 M | 3.431 M | 3.655 M | 3.071 M | 3.889 M | 4.569 M | 2.769 M | |
| Accounts Payable | 1.825 M | 1.585 M | 1.337 M | 1.031 M | 1.210 M | 1.838 M | 1.307 M | |
| Other liabilities | 5.843 M | 5.644 M | 5.431 M | 5.213 M | 5.409 M | 5.306 M | 5.545 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 5.843 M | 5.644 M | 5.431 M | 5.213 M | 5.409 M | 5.306 M | 5.545 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 2.207 M | 1.613 M | 1.545 M | 6.772 M | 11.382 M | 8.863 M | 6.927 M | |
| Common stock | 192.599 M | 192.605 M | 193.628 M | 206.036 M | 207.636 M | 207.637 M | 208.137 M | |
| Retained earnings | -190.392 M | -190.992 M | -192.083 M | -199.264 M | -196.254 M | -198.875 M | -201.312 M |